tDCS + SLT for Post-Stroke Aphasia
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether combining brain stimulation with speech therapy can improve language recovery in individuals who struggle to find words after a stroke. The trial will compare two groups: one receiving active brain stimulation (Transcranial Direct Current Stimulation, or tDCS) and the other receiving a sham treatment, both paired with speech therapy. Individuals who have had a single stroke affecting the left side of the brain, have experienced language difficulties for at least six months, and primarily speak English might be a good fit.
As an unphased trial, this study provides a unique opportunity to contribute to innovative research that could enhance future stroke recovery therapies.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this combination of tDCS and SLT is safe for post-stroke aphasia treatment?
Previous studies have shown that transcranial direct current stimulation (tDCS) is safe for people recovering from a stroke. This treatment uses a gentle electrical current to stimulate the brain and is non-invasive, meaning it doesn't involve surgery or entering the body. Research indicates that combining tDCS with speech-language therapy (SLT) can aid people with post-stroke aphasia, a condition that affects speaking or understanding language due to brain damage.
Most participants in these studies did not experience serious side effects. Some reported minor issues like tingling or itching on the skin where the electrodes were placed, but these were temporary and not harmful. Overall, tDCS is considered well-tolerated, and when used with SLT, it may improve language skills without causing significant adverse effects.12345Why are researchers excited about this trial?
Researchers are excited about using transcranial direct current stimulation (tDCS) with speech-language therapy (SLT) for post-stroke aphasia because it offers a novel approach to enhancing brain recovery. Unlike traditional speech therapy alone, which is the standard treatment, tDCS provides a gentle electrical current to the scalp, potentially boosting the brain's ability to relearn language skills. The combination of tDCS with SLT could lead to faster and more effective improvements in speech and language abilities. This method is promising because it targets the brain's plasticity, which is its ability to form new connections, offering hope for better outcomes in aphasia recovery.
What evidence suggests that this trial's treatments could be effective for post-stroke aphasia?
Research shows that combining transcranial direct current stimulation (tDCS) with speech-language therapy (SLT) may assist individuals who have difficulty speaking after a stroke. In this trial, participants will receive either active tDCS with SLT or sham tDCS with SLT. Studies suggest that active tDCS combined with SLT can enhance language skills, such as speaking clearly and naming objects. Specifically, early findings indicate that anodal-tDCS, which uses mild electrical stimulation on the brain, can lead to noticeable improvements in naming and communication. This method is considered a promising addition to traditional speech therapy, offering potential benefits for treating speech and language difficulties after a stroke. The gentle electrical stimulation is thought to help the brain reorganize and improve language processing.23678
Who Is on the Research Team?
Dana Moser, PhD, CCC-SLP
Principal Investigator
University of Arkansas
Are You a Good Fit for This Trial?
This trial is for individuals aged 18-80 who have had a stroke on the left side of their brain at least 6 months ago, resulting in aphasia. They must speak English natively and have good hearing and vision. People with severe comprehension deficits, other neurological diseases or major mental illnesses, conditions not suitable for MRI or tDCS (like seizures), or pregnant women cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Baseline Assessment
Participants complete the Neuropsychological Testing Battery and the first round of outcome measures as pre-testing before starting SLT
Intervention Phase 1
Participants receive 2 weeks of Speech-Language Therapy (SLT) with either active tDCS or sham tDCS
Outcome Testing 1
Participants complete post-testing for the 1st SLT phase and pre-testing for the 2nd SLT phase
Intervention Phase 2
Participants receive another 2 weeks of SLT with the other tDCS condition
Outcome Testing 2
Participants complete post-testing for the 2nd SLT phase
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Active Transcranial Direct Current Stimulation with SLT
- Sham Transcranial Direct Current Stimulation with SLT
Active Transcranial Direct Current Stimulation with SLT is already approved in European Union, United States, Canada, Japan, China, Switzerland for the following indications:
- Post-stroke aphasia rehabilitation
- Post-stroke aphasia rehabilitation
- Post-stroke aphasia rehabilitation
- Post-stroke aphasia rehabilitation
- Post-stroke aphasia rehabilitation
- Post-stroke aphasia rehabilitation
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Arkansas
Lead Sponsor